Exchange: NASDAQ·Updated 05:02 PM EST

KPRX News

News
all
press releases
The company announced a $24 million private placement, led by Perceptive Advisors and ADAR1 Capital Management.
Stocktwits
Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting...
PR Newswire
Kiora Pharmaceuticals (KPRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks

Advertisement|Remove ads.